EGFR and head and neck squamous cell carcinoma: Knowing about the importance of cell cycle regulation and culturing conditions in terms of radiosensitization by EGFR targeting, we asked whether EGFR targeting by cetuximab and erlotinib induces cellular radiosensitization of human papilloma virus (HPV)-negative HNSCC cells under different culturing conditions.